The global in-vitro toxicology testing market size was valued at USD 13.26 billion in 2018 and to reach around USD 28.71 Billion by 2026. It is projected to expand at a CAGR of 12.4% during the forecast period 2019 to 2026.
In vitro toxicology testing is done in order to examine the presence or absence of harmful chemicals or toxins in cells of an organism. This testing process is used to recognise dangerous chemical substances and helps in detecting toxicity at the early stages of development of new products like agricultural chemicals, cosmetics, drugs and food additives. The in vitro toxicology testing is done for evaluating safety in drug development and also to rank the chemicals in terms of their potency. The global in vitro toxicology testing market is witnessing significant growth due to an increase in the number of R&D procedures where in vitro testing is required. Also, ban on animal testing is also significantly contributing to the growth of this market. Another factor boosting the market of in vitro toxicology testing is the growing environmental concerns and to ensure that no toxins via the agricultural chemicals, etc. enter the environment. In addition, advancements in the 3D cell culture is also boosting this market.
The report analyzes and forecasts the in-vitro toxicology testing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of in-vitro toxicology testing, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major in-vitro toxicology testing companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of in-vitro toxicology testing upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of in-vitro toxicology testing and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global in-vitro toxicology testing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the in-vitro toxicology testing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of in-vitro toxicology testing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Some of the major companies in the market are Abbott; Covance; GE Healthcare; Quest Diagnostics, Inc.; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories; Catalent Pharma Solutions; Cyprotex, Agilent Technologies; Charles River Laboratories; Merck KgaA; and Eurofins Scientific, Inc.
Report Segmentation:
Technology Outlook (Revenue, USD Million, 2014 - 2025)
Cell Culture Tech
High Throughput Tech
Molecular Imaging
OMICS Tech
Method Outlook (Revenue, USD Million, 2014 - 2025)
Cellular Assay
Biochemical Assay
In Silica
Ex-vivo
Application Outlook (Revenue, USD Million, 2014 - 2025)
Systemic Toxicology
Dermal Toxicity
Endorine Disruption
Occular Toxicity
Others
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Pharmaceutical Industry
Cosmetics & Household Products
Diagnostics
Chemicals Industry
Food Industry
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Middle East & Africa
South Africa
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global In-vitro Toxicology Testing Market, By Technology
7.1. In-vitro Toxicology Testing Market, By Technology Type, 2020-2027
7.1.1. CTC Detection & Enrichment Methods
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. CTC Direct Detection Methods
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. CTC Analysis
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global In-vitro Toxicology Testing Market, By Application
8.1. In-vitro Toxicology Testing Market, By Application, 2020-2027
8.1.1. Clinical/Liquid Biopsy
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Research
8.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global In-vitro Toxicology Testing Market, By Product
9.1. In-vitro Toxicology Testing Market, By Filling Material, 2020-2027
9.1.1. Kits & Reagents
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Blood Collection Tubes
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Devices or Systems
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global In-vitro Toxicology Testing Market, By Specimen
10.1. In-vitro Toxicology Testing Market, By End-use, 2020-2027
10.1.1. Blood
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Bone Marrow
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Other Body Fluids
10.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global In-vitro Toxicology Testing Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.1.6.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.6.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.7.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.2.8.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.6.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.7.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.3.8.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.6.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.7.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Technology (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Application (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Product(2016-2027)
11.4.8.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.5.4. Market Revenue and Forecast, By Specimen(2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Technology (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Application (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Product(2016-2027)
11.5.6.4. Market Revenue and Forecast, By Specimen(2016-2027)
Chapter 12. Company Profiles
12.1. Abbott
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Agilent Technologies
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. GE Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bio-Rad
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Merck KGaA
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers